Opinions about scientific advances blur party-political lines
By Matthew Nisbet and Ezra Markowitz,
The Conversation
| 02. 19. 2014
Reading about the rapid pace of advances in biomedicine, you may have wondered why more politically liberal countries like Germany and Canada have stronger restrictions on embryonic stem cell research than the politically conservative US.
History and happenstance play a role, but these differences also reflect public concerns that do not conform to traditional left or right political ideologies.
As debates over stem cell research continue and as conflicts over other biomedical advances emerge, a recurring set of questions is likely to be seen. Do scientific breakthroughs promote or undermine social progress? Is research being pursued too cautiously or too quickly? Do scientists respect or cross moral boundaries?
In a study, just published in PLOS ONE, we analysed a series of surveys collected between 2002 and 2010 to better understand what the US public thinks about stem cell research and how they formed these opinions. We were able to distinguish between the different factors influencing their beliefs. At play were factors such as traditional loyalties to political parties and more fundamental beliefs about science and society.
Our results indicate...
Related Articles
By Gregory Laub and Hannah Glaser, MedPage Today | 08.07.2025
In this MedPage Today interview, Leigh Turner, PhD, a professor of health policy and bioethics at the University of California Irvine, unpacks the growing influence of stem cell clinics and the blurred line between medicine and marketing. He explains how...
By Gina Kolata, The New York Times | 06.20.2025
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need...
By Christina Jewett, The New York Times | 06.05.2025
Health Secretary Robert F. Kennedy Jr. recently declared that he wanted to expand access to experimental therapies but conceded that they could be risky or fraudulent.
In a podcast with Gary Brecka, who describes himself as a longevity expert...
By Mike Baker, The New York Times | 02.25.2025
As investigators struggled for weeks to find who might have committed the brutal stabbings of four University of Idaho students in the fall of 2022, they were focused on a key piece of evidence: DNA on a knife sheath that...
